Plain-English translation of NCT06315322 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This is a long-term safety study of brivaracetam, a seizure medication, in children and teenagers with childhood absence epilepsy or juvenile absence epilepsy. The study follows people who have already participated in earlier trials of this medication and want to continue taking it. Researchers want to make sure the medication remains safe and tolerable when used over many months or years.
While earlier studies have tested whether this medication works for absence seizures, doctors need to understand how safe it is with long-term use—especially in young people who may take it for months or years. This study gathers that important safety information.
You would take the medication by mouth twice a day, either as a liquid or tablet, at doses determined by your doctor. You would attend regular study visits where your doctor checks on how you are doing, watches for any side effects, and may do blood tests or other monitoring. The study is designed to follow you for an extended period to understand how well the medication works and how safe it is over time.
AI-generated summary from trial data · Jul 12, 2026 · Not medical advice
United States